Advanced/Metastatic Clinical Trials in Shenzhen, Guangdong
3 recruitingShenzhen, Guangdong, China
Showing 1–3 of 3 trials
Recruiting
Phase 1Phase 2
Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC
Non-small Cell Lung CancerAdvanced/Metastatic
Beijing Biotech60 enrolled1 locationNCT07641023
Recruiting
Phase 1Phase 2
Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC
Triple-Negative Breast CancerHER2-positive Breast CancerBreast Cancer (Advanced/Metastatic)
Beijing Biotech60 enrolled1 locationNCT07510802
Recruiting
Phase 1Phase 2
Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC
Non-small Cell Lung CancerAdvanced/Metastatic NSCLC
Beijing Biotech48 enrolled1 locationNCT07467863